The p16INK4a protein: A cytological marker for detecting high grade intraepithelial neoplasia of the uterine cervix;La protéine p16INK4a: Un marqueur cytologique pour détecter les néoplasies intraépithéliales de haut grade du col utérin

Annales de Pathologie

Volumn 26, Issue 5, 2006, Pages 397-402

  Bergeron, Christine ^a   Wentzensen, Nicolas ^b   Cas, Frederic ^a   Doeberitz, Magnus Von Knebel ^b  

^a LABORATOIRE CERBA   (France)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

ASC US; Biomarker; Cervical screening; Human papillomavirus (HPV); Liquid based cytology; LSIL; p16INK4a

Indexed keywords

PROTEIN P16INK4A;

ARTICLE; BASAL CELL; CELL DIFFERENTIATION; CORRELATION ANALYSIS; CYTOLOGY; DIAGNOSTIC PROCEDURE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; PREDICTION; PROTEIN ANALYSIS; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL; TUMOR DIAGNOSIS; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX TUMOR; CHEMISTRY; FEMALE; PATHOLOGY;

CERVICAL INTRAEPITHELIAL NEOPLASIA; CYCLIN-DEPENDENT KINASE INHIBITOR P16; FEMALE; HUMANS; UTERINE CERVICAL NEOPLASMS;

EID: 33845924079     PISSN: 02426498     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0242-6498(06)70746-5     Document Type: Article

References (22)

1. Solomon D, Davey D, Kurman R, Moriarty A, O'Connor D, Prey M et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 2002 ; 287 : 2114-9.
2. Agence Nationale d'Accréditation et d'Évaluation en Santé. Recommandations pour la pratique clinique. Conduite à tenir devant une patiente ayant un frottis cervico-utérin anormal. Actualisation 2002 (site : www.anaes.fr).
3. Wright TC, Cox JT, Massad LS, Twiggs LB, Wilkinson EJ. ASCCP-Sponsored Consensus Conference. 2001 Consensus Guidelines for the management of women with cervical cytological abnormalities. JAMA 2002 ; 287 : 2120-9.
4. Arbyn M, Buntinx F, van Ranst M, Paraskevaidis E, Martin-Hirsh P, Dillner J. Virologic versus cytologic triage of women with equivocal pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia. J Natl Cancer Inst 2004 ; 96 : 280-93.
5. Khleif SN, DeGregori J, Yee CL, Otterson GA, Kaye FJ, Nevins JR et al. Inhibition of cyclin D-CDK4/CDK6 activity is associated with an E2F-mediated induction of cyclin kinase inhibitor activity. Proc Natl Acad Sci USA 1996 ; 93 : 4350-4.
6. Sano T, Oyama T, Kashiwabara K, Fukuda T, Nakajima T. Expression status of p16 protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions. Am J Pathol 1998 ; 153 : 1741-8.
7. Klaes R, Friedrich T, Spitkovsky D, Ridder R, Rudy W, Petry U et al. Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer 2001 ; 92 : 276-84.
8. Agoff SN, Lin P, Morihara J, Mao C, Kiviat NB, Koutsky LA. p16(INK4a) expression correlates with degree of cervical neoplasia: a comparison with Ki-67 expression and detection of high-risk HPV types. Mod Pathol 2003 ; 16 : 665-73.
9. Nieh S, Chen SF, Chu TY, Lai HC, Fu E. Expression of p16INK4A in Papanicolaou smears containing atypical squamous cells of undetermined significance from the uterine cervix. Gynecol Oncol 2003 ; 91 : 201-8.
10. INK4a- positive cells in cervical cytology samples. Acta Cytol 2004 ; 48 : 771-82.
11. Sahebali S, Depuydt CE, Segers K, Moeneclaey LM, Vereecken AJ, Van Marck E et al. P16INK4a as an adjunct marker in liquid-based cervical cytology. Int J Cancer 2004 ; 108 : 871-6.
12. Sahebali S, Depuydt CE, Boulet GA, Arbyn M, Moeneclay LM, Vereecken AJ et al. Immunocytochemistry in liquid based cervical cytology: analysis of clinical use following a cross-sectional study. Int J Cancer 2006 ; 118 : 1254-60.
13. INK4a stained cervical squamous cells in liquid based cytology samples. Cancer 2005 ; 105 : 461-7.
14. INK4a positive cells to identify patients with high grade cervical intraepithelial neoplasia. Cancer in press.
15. Bergeron C, Fagnani F. Performance of a new, liquid-based cervical screening technique in the clinical setting of a large French laboratory. Acta Cytol 2003 ; 47 : 753-61.
16. Wang SS, Trunk M, Schiffman M, Herrero R, Sherman ME, Burk RD et al. Validation of p16INK4a as a marker of oncogenic human papillomavirus infection in cervical biopsies from a population-based cohort in Costa Rica. Cancer Epidemiol Biomarkers Prev 2004 ; 13 : 1355-60.
17. Negri G, Vittadello F, Romano F, Kasal A, Rivasi F, Girlando S et al. P16(INK4a) expression and progression risk of low-grade intraepithelial neoplasia of the cervix uteri. Virchows Arch 2004 ; 445 : 616-20.
18. INK4a expression correlates with degree of cervical neoplasia: a comparison with Ki-67 expression and detection of high-risk HPV types. Mod Pathol 2003 ; 16 : 665-7.
19. Klaes R, Benner A, Friedrich T, Ridder R, Herrington S, Jenkins D et al. p16INK4a immunohistochemistry improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia. Am J Surg Pathol 2002 ; 26 : 1389-99.
20. Guo M, Hu L, Baliga M, He Z, Hughson MD. The Predictive Value of p16(INK4a) and Hybrid Capture 2 Human Papillomavirus Testing for High-Grade Cervical Intraepithelial Neoplasia. Am J Clin Pathol 2004 ; 122 : 894-901.
21. Yoshida T, Fukuda T, Sano T, Kanuma T, Owada N, Nakajima T. Usefulness of liquid-based cytology specimens for the immunocytochemical study of p16 expression and human papillomavirus testing: a comparative study using simultaneously sampled histology materials. Cancer 2004 ; 102 : 100-8.
22. Nieh S, Chen SF, Chu TY, Lai HC, Lin YS, Fu E et al. Is p16(INK4A) expression more useful than human papillomavirus test to determine the outcome of atypical squamous cells of undetermined significance-categorized Pap smear? A comparative analysis using abnormal cervical smears with follow-up biopsies. Gynecol Oncol 2005 ; 97 : 35-40.